-
1دورية أكاديمية
المؤلفون: Li L; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China., Wang K; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China., Wang M; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China., Tao J; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China., Li X; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China., Liu Z; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China., Li N; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China., Qiu X; The Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China., Wei H; The Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China., Lin Y; Fujian Provincial Maternity and Children's Hospital, Fuzhou, Fujian, China., He Y; National Research Institute for Family Planning, National Human Genetic Resource Center, Beijing, China., Deng Y; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China., Kang H; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China., Li Y; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China., Yu P; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. yup@scu.edu.cn.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China. yup@scu.edu.cn., Wang Y; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. wyxyanping@163.com.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China. wyxyanping@163.com., Zhu J; National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. zhujun028@163.com.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China. zhujun028@163.com., Liu H; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China. liuhm@scu.edu.cn.; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. liuhm@scu.edu.cn.
المصدر: Nature communications [Nat Commun] 2024 Jun 21; Vol. 15 (1), pp. 5312. Date of Electronic Publication: 2024 Jun 21.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
مواضيع طبية MeSH: Maternal Exposure*/adverse effects , Premature Birth*/epidemiology , Pregnancy Trimester, First* , Pregnancy Outcome*/epidemiology, Humans ; Female ; Pregnancy ; China/epidemiology ; Adult ; Prospective Studies ; Dydrogesterone/adverse effects ; Progesterone ; Birth Cohort ; Infant, Newborn ; Abortion, Spontaneous/epidemiology ; Abortion, Spontaneous/chemically induced ; Stillbirth/epidemiology ; Infant, Low Birth Weight ; Longitudinal Studies ; Incidence ; Young Adult
-
2دورية أكاديمية
المؤلفون: Zhao S; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Wang Y; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Zhou A; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Liu X; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Zhang Y; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Zhang J; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
المصدر: PeerJ [PeerJ] 2024 May 29; Vol. 12, pp. e17492. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: PeerJ Inc Country of Publication: United States NLM ID: 101603425 Publication Model: eCollection Cited Medium: Internet ISSN: 2167-8359 (Electronic) Linking ISSN: 21678359 NLM ISO Abbreviation: PeerJ Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Receptor, ErbB-2*/metabolism , Receptor, ErbB-2*/genetics , Neoadjuvant Therapy*/methods, Humans ; Female ; Retrospective Studies ; Middle Aged ; China/epidemiology ; Prognosis ; Adult ; Aged ; Chemotherapy, Adjuvant ; Treatment Outcome ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism
-
3دورية أكاديمية
المؤلفون: Jiang H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Zhong J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Wang J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Song G; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Di L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Shao B; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Zhang R; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Liu Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Zhu A; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Wang N; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China., Li H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
المصدر: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (10), pp. e7249.
نوع المنشور: Journal Article; Comparative Study
بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Breast Neoplasms*/metabolism , Piperazines*/administration & dosage , Piperazines*/therapeutic use , Pyridines*/therapeutic use , Pyridines*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Aminopyridines*/administration & dosage , Aminopyridines*/therapeutic use , Receptor, ErbB-2*/metabolism , Benzimidazoles*/administration & dosage , Benzimidazoles*/therapeutic use , Receptors, Estrogen*/metabolism , Progression-Free Survival*, Humans ; Female ; Middle Aged ; China ; Receptors, Progesterone/metabolism ; Aged ; Adult ; Retrospective Studies ; Disease Progression ; Antineoplastic Agents, Hormonal/therapeutic use ; Antineoplastic Agents, Hormonal/administration & dosage
-
4دورية أكاديمية
المؤلفون: Wu X; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China., Wei D; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China., Liu X; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China., Yuchi Y; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China., Liao W; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China., Wang C; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China., Huo W; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China., Mao Z; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China. Electronic address: mzx@zzu.edu.cn.
المصدر: The Science of the total environment [Sci Total Environ] 2024 Mar 25; Vol. 918, pp. 170621. Date of Electronic Publication: 2024 Feb 03.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0330500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1026 (Electronic) Linking ISSN: 00489697 NLM ISO Abbreviation: Sci Total Environ Subsets: MEDLINE
مواضيع طبية MeSH: Air Pollution, Indoor*/analysis, Humans ; Female ; Cross-Sectional Studies ; Progesterone/analysis ; Progestins/analysis ; Androgens/analysis ; Androstenedione/analysis ; Mendelian Randomization Analysis ; Cooking ; Testosterone ; China
-
5دورية أكاديمية
المؤلفون: Lin M; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast and Urinary Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Luo T; Breast Disease Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Multi-Omics Laboratory of Breast Diseases, State Key Laboratory of Biotherapy, National Collaborative, Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China., Jin Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Zhong X; Breast Disease Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Multi-Omics Laboratory of Breast Diseases, State Key Laboratory of Biotherapy, National Collaborative, Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China., Zheng D; Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China., Zeng C; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Guo Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Wu J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Key Laboratory of Breast Cancer in Shanghai, Shanghai, China., Shao ZM; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Key Laboratory of Breast Cancer in Shanghai, Shanghai, China., Hu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast and Urinary Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Yang W; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China., Zhang J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China.
المصدر: Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 851-862. Date of Electronic Publication: 2023 Nov 07.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/therapy , Breast Neoplasms*/metabolism, Humans ; Female ; Receptor, ErbB-2/metabolism ; Cohort Studies ; China ; Prognosis ; Receptors, Progesterone/metabolism
-
6دورية أكاديمية
المؤلفون: Ding W; Department of Oncological Surgery, Shaoxing Second Hospital, Shaoxing, 312000, China.; Department of Clinical Medicine, Shaoxing University School of Medicine, Shaoxing, China., Ye D; Department of Oncological Surgery, Shaoxing Second Hospital, Shaoxing, 312000, China., Chen H; Department of Oncological Surgery, Shaoxing Second Hospital, Shaoxing, 312000, China., Lin Y; Department of Early Childhood Education, Shaoxing Vocational and Technical College, Shaoxing, China., Li Z; Department of Oncological Surgery, Shaoxing Second Hospital, Shaoxing, 312000, China. lza120120@163.com., Tu C; Department of Surgery, Shaoxing Second Hospital, Shaoxing, 312000, China. chuanjiantu@163.com.
المصدر: Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Mar; Vol. 31 (2), pp. 295-304. Date of Electronic Publication: 2024 Jan 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*, Female ; Humans ; China ; Receptor, ErbB-2/metabolism ; Prognosis ; Disease-Free Survival ; Kaplan-Meier Estimate ; Receptors, Progesterone/metabolism ; Biomarkers, Tumor/metabolism
-
7دورية أكاديمية
المؤلفون: Wang L; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Mao Z; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Liu X; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Wei D; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Liu P; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Nie L; Department of Occupational and Environmental Health Sciences, College of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China., Fan K; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Kang N; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Song Y; Department of Occupational and Environmental Health Sciences, College of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China., Xu Q; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Wang J; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Wang M; Department of Occupational and Environmental Health Sciences, College of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China., Liao W; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Jing T; School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China., Li W; Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Wang C; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China., Huo W; Department of Occupational and Environmental Health Sciences, College of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, Henan, People's Republic of China. huowenqian@zzu.edu.cn.
المصدر: Clinical epigenetics [Clin Epigenetics] 2021 Sep 26; Vol. 13 (1), pp. 181. Date of Electronic Publication: 2021 Sep 26.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: BiomedCentral Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE
مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Progesterone/*pharmacology , Suppressor of Cytokine Signaling 3 Protein/*pharmacology, Adult ; Aged ; Case-Control Studies ; China/epidemiology ; DNA Methylation/drug effects ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Prevalence ; Progesterone/administration & dosage ; Risk Factors ; Rural Population/statistics & numerical data ; Suppressor of Cytokine Signaling 3 Protein/administration & dosage
-
8دورية أكاديمية
المؤلفون: Jin Z; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Li J; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Yang E; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Shi H; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Bu Z; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Niu W; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Wang F; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Huo M; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Song H; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Zhang Y; Reproductive Medicine Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. luna020996@126.com.; Zhengzhou, People's Republic of China. luna020996@126.com.
المصدر: Reproductive biology and endocrinology : RB&E [Reprod Biol Endocrinol] 2021 Oct 09; Vol. 19 (1), pp. 154. Date of Electronic Publication: 2021 Oct 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101153627 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7827 (Electronic) Linking ISSN: 14777827 NLM ISO Abbreviation: Reprod Biol Endocrinol Subsets: MEDLINE
مواضيع طبية MeSH: Pregnancy Rate* , Reproductive Techniques, Assisted*/statistics & numerical data, Embryo Transfer/*methods , Endometrium/*pathology , Progesterone/*therapeutic use, Adult ; Blastocyst ; China/epidemiology ; Cohort Studies ; Cryopreservation ; Embryo Implantation/drug effects ; Endometrium/drug effects ; Female ; Fertilization in Vitro/methods ; Fertilization in Vitro/statistics & numerical data ; Hormone Replacement Therapy ; Humans ; Luteal Phase/drug effects ; Luteal Phase/metabolism ; Organ Size/physiology ; Pregnancy ; Pregnancy Outcome/epidemiology ; Progesterone/administration & dosage ; Retrospective Studies ; Treatment Outcome
-
9دورية أكاديمية
المؤلفون: Liping Yang -; Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Yunnan, China., Guangyun Zhang -; Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Yunnan, China., Deqiang Feng -; Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Yunnan, China., Maomao Zhang -; Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Yunnan, China., Xiaohua Duan -; Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Yunnan, China.
المصدر: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2023 May; Vol. 36 (3), pp. 863-871.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Faculty of Pharmacy, University of Karachi Country of Publication: Pakistan NLM ID: 9426356 Publication Model: Print Cited Medium: Internet ISSN: 1011-601X (Print) Linking ISSN: 1011601X NLM ISO Abbreviation: Pak J Pharm Sci Subsets: MEDLINE
مواضيع طبية MeSH: Drugs, Chinese Herbal*/pharmacology , Drugs, Chinese Herbal*/therapeutic use , Leiomyoma*/drug therapy , Uterine Neoplasms*/drug therapy, Mice ; Female ; Animals ; Humans ; China ; Medicine, Chinese Traditional ; Receptors, Progesterone
SCR Organism: Kunming mice
-
10دورية أكاديمية
المؤلفون: Zeng H; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wu S; The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, China., Ma F; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Ji JS; Vanke School of Public Health, Tsinghua University, Beijing, China., Lu L; Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale Cancer Center, New Haven, Connecticut, USA., Ran X; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Shi J; The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, China., Li D; The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, China., An L; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zheng R; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang S; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Chen W; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wei W; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., He Y; The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, China., He J; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
المصدر: Cancer medicine [Cancer Med] 2023 May; Vol. 12 (9), pp. 10865-10876. Date of Electronic Publication: 2023 Mar 23.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*/diagnosis , Breast Neoplasms*/epidemiology , Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/diagnosis , Triple Negative Breast Neoplasms*/epidemiology , Healthcare Disparities*, Female ; Humans ; Asian People ; China/epidemiology ; Obesity/epidemiology ; Obesity/complications ; Overweight/complications ; Prognosis ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Receptors, Progesterone/metabolism